I
Intalight
A healthcare start-up that develops and produces high-end ophthalmic imaging equipment
About Intalight
SVision Imaging is a startup that operates in the medical technology sector, specifically focusing on optical imaging. The company has developed a unique optical system that allows for comprehensive scanning of the eye, capturing a 16mm line scan and 15mm x 12mm blood flow imaging in a single scan. This technology is designed to increase the efficiency of eye examinations and reduce the chances of missed diagnoses.
SVision Imaging's technology is optimized for swept-source optical coherence tomography (SS-OCTA), a non-invasive imaging technique that uses light waves to take cross-section pictures of the retina. This allows for the detection of any abnormal blood vessels, contributing to a more accurate diagnosis.
The company's business model revolves around selling their imaging technology to healthcare providers, particularly those specializing in ophthalmology. They have already made significant strides in the market, with their technology being adopted by renowned institutions such as the University of Washington and Beijing Tongren Hospital.
SVision Imaging also invests in research and development, as evidenced by their Silicon Valley R&D center. This suggests a commitment to continuous innovation and improvement of their technology.
In summary, SVision Imaging is a promising startup in the medtech sector, offering innovative optical imaging solutions that improve the efficiency and accuracy of eye examinations.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2014
- Headquarters
- San Jose, United States
- Employees
- 3
- Open positions
- None listed
- Dealroom signal
- 60.9/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Ophthalmology, Medical Imaging, Health Diagnostics, Hard Tech, DT and LS, science-based
- Technology
- Deep Tech
- Business model
- Manufacturing
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES DOther financing | Oct 2025 | — | $633M | Shenzhen Cornerstone Asset Management · Qianhai FOF | ↗ |
| SERIES DOther financing | Apr 2024 | $14M | $495M | Haitong Kaiyuan · Hefei Haitong Small and Medium-sized Fund Partnership | ↗ |
Growth signals
Latest recorded traffic for Intalight is 2.9K monthly website visits, up 360.3% over the last three months. Intalight's team declined 82.4% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- LILangsheng Investment
Series B and later15 investors entered at this stage
Ming Capital
Addor Capital- AGAier Eye Hospital Group
CD Capital
Qianhai FOF
Shenzhen Capital Group
CICC- CIChina Life Private Equity Investment
- FVFlyfot Ventures
- LFLingang Blue Bay Fund
- SFShaanxi Investment Growth Fund
- HGHuaxia Eye Hospital Group
- HKHaitong Kaiyuan
- HPHefei Haitong Small and Medium-sized Fund Partnership
- SMShenzhen Cornerstone Asset Management
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Intalight on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Intalight’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.